FMVQX | VEVYX | FMVQX / VEVYX | |
Total Expense Ratio | 0.75 | 0.66 | 114% |
Annual Report Gross Expense Ratio | 0.84 | 0.66 | 127% |
Fund Existence | 7 years | 13 years | - |
Gain YTD | 9.471 | 3.098 | 306% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 376M | 17.1B | 2% |
Annual Yield % from dividends | 1.21 | 1.02 | 119% |
Returns for 1 year | 4.45 | -8.52 | -52% |
Returns for 3 years | 26.35 | 8.66 | 304% |
Returns for 5 years | 73.64 | 40.03 | 184% |
Returns for 10 years | N/A | 55.50 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNNX | 73.98 | 1.07 | +1.47% |
Janus Henderson Global Life Sciences N | |||
CDHAX | 37.19 | 0.28 | +0.76% |
Calvert International Responsible Idx A | |||
FAERX | 38.95 | 0.29 | +0.75% |
Fidelity Advisor Overseas M | |||
DCEMX | 15.58 | 0.07 | +0.45% |
Dunham Emerging Markets Stock C | |||
RICEX | 67.05 | 0.08 | +0.12% |
American Funds Invmt Co of Amer R4 |